Termination of Bridge Biotherapeutics’s Collaboration and License Agreement with Boehringer Ingelheim Read more
ImmunityBio’s hAd5 COVID-19 Vaccine Candidate Stimulates Memory T-Cell Recall in Patients Infected with SARS-CoV-2 Read more
Lynparza approved in the EU for the treatment of BRCA- mutated metastatic castration-resistant prostate cancer Read more
TFF Pharmaceuticals and Felix Biotechnology Sign Letter of Intent for a Collaboration, Development and License Agreement Read more
Isotopia Molecular Imaging begins clinical supply collaboration with Y-mAbs Therapeutics, Inc. Read more